Skip to main content

Table 1 Incidence of symptoms in patients

From: Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study

 

ME CFS patients

Long term SARS-Cov-2

 

N = 55

N = 59

Age (year)

46 ± 3

46 ± 2

Weight (kg)

66 ± 2

72 ± 2

Women

43 (77%)

43 (73%)

Fatigue onset (months)a

34 ± 3

18 ± 3

Myalgia

50/55 (91%)

45/59 (76%)

Sleep problems

45/55 (82%)

48/59 (81%)

Cognitive dysfunction

48/55 (87%)

48/59 (81%)

Digestive problemsa

47/55 (85%)

37/59 (63%)

Post exertional malaise

48/55 (87%)

43/59 (78%)

Psychological stress

41/55 (75%)

41/59 (69%)

  1. aSignificant difference (p < 0.05)